Vericel Corp. (VCEL)
33.70
+0.11
(+0.33%)
USD |
NASDAQ |
Apr 10, 16:00
33.71
+0.01
(+0.03%)
After-Hours: 20:00
Vericel Profit Margin (Quarterly) : 25.01% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -357.4% |
| Marker Therapeutics, Inc. | -154.4% |
| Moderna, Inc. | -121.8% |
| Krystal Biotech, Inc. | 47.99% |
| Tenaya Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.26% |
| Return on Assets | 3.70% |
| Return on Invested Capital | 3.99% |
| Gross Profit Margin (Quarterly) | 78.70% |
| Operating Margin (Quarterly) | 24.12% |
| Return on Net Operating Assets | 6.27% |